Scholar Rock Holding Corp SRRK:NASDAQ

RT Quote | Last NASDAQ LS, VOL From CTA | USD
after hours iconAfter Hours: Last | 4:00 PM EDT
14.69UNCH (UNCH)
Volume
15,914
Close
14.69quote price arrow down-0.37 (-2.46%)
Volume
572,008
52 week range
5.56 - 21.17
Loading...
  • Open15.00
  • Day High15.15
  • Day Low13.96
  • Prev Close15.06
  • 52 Week High21.17
  • 52 Week High Date12/28/23
  • 52 Week Low5.56
  • 52 Week Low Date05/31/23

Key Stats

  • Market Cap1.172B
  • Shares Out79.75M
  • 10 Day Average Volume0.69M
  • Dividend-
  • Dividend Yield-
  • Beta0.89
  • YTD % Change-21.86

KEY STATS

  • Open15.00
  • Day High15.15
  • Day Low13.96
  • Prev Close15.06
  • 52 Week High21.17
  • 52 Week High Date12/28/23
  • 52 Week Low5.56
  • 52 Week Low Date05/31/23
  • Market Cap1.172B
  • Shares Out79.75M
  • 10 Day Average Volume0.69M
  • Dividend-
  • Dividend Yield-
  • Beta0.89
  • YTD % Change-21.86

RATIOS/PROFITABILITY

  • EPS (TTM)-2.08
  • P/E (TTM)-7.05
  • Fwd P/E (NTM)-7.10
  • EBITDA (TTM)-168.451M
  • ROE (TTM)-68.30%
  • Revenue (TTM)-
  • Gross Margin (TTM)-
  • Net Margin (TTM)-405.21%
  • Debt To Equity (MRQ)22.21%

EVENTS

  • Earnings Date05/07/2024(est)
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest On Scholar Rock Holding Corp

 

Content From Our Affiliates

Profile

MORE
Scholar Rock Holding Corporation is a biopharmaceutical company. The Company is focused on the discovery and development of medicines for the treatment of serious diseases, including neuromuscular disorders, cancer, fibrosis and anemia. The Company’s product candidate includes apitegromab, an inhibitor of the activation of latent myostatin for the treatment of spinal muscular atrophy (SMA) and is in the treatment of other myostatin-related disorders. Its product candidate...
David Hallal
Independent Chairman of the Board
Jay Backstrom M.D.
President, Chief Executive Officer, Director
Edward Myles CPA
Chief Financial Officer, Chief Operating Officer
Junlin Ho J.D.
General Counsel, Corporate Secretary
Address
301 BINNEY STREET, 3RD FLOOR
Cambridge, MA
02142
United States

Top Peers

SYMBOLLASTCHG%CHG
CGEM
Cullinan Therapeutics Inc
29.35+0.95+3.35%
PHVS
Pharvaris NV
22.62-0.06-0.26%
BLTE
Belite Bio Inc
43.20-0.10-0.23%
SYRE
Spyre Therapeutics Inc
34.24-1.53-4.28%
AKRO
Akero Therapeutics Inc
22.02-0.09-0.41%